These estimations are approximate, derived from reagents, flow cell and interpretation expenses alone. They do not encompass potential expenses associated with library preparation, data analysis, warranty, or service and support. We recommend users conduct their own assessments before finalizing any procurement decisions. For further assistance, please reach out to OncoDNA’s sales team.
* Please note that the competitor placeholder values mentioned above represent published list prices of the Illumina TSO500 kit consumables, BioIT process and interpretation software. Third-party trademarks mentioned belong to their respective owners and are utilized here solely for identification purposes, with no implication of endorsement.
** As demonstrated in a recent study (1), the exceptional coverage uniformity OncoDEEP® Kits allows to sequence more samples on the same budget without sacrificing the quality of result at all. Having eliminated the need to over sequence, OncoDEEP® Kits allow users to pool more samples on the sequencing platform, ultimately leading to cost reduction. It has been reported that OncoDEEP® DNA Kit supports the pooling of at least 3X more samples when compared to TSO500.
(▲) Secondary analysis cost calculation model: Licence fee per year: 25.583€ / (24 * 30) (Quantity of samples per week: 24 * number of sequencing weeks)
(1) Comprehensive Genomic Profiling of solid tumor patients with the OncoDEEP assay for broad analysis in clinical diagnostics, Hendrikus Jan Dubbink, et al. (AACR 2024)
